Combining rituximab and mycophenolate mofetil was significantly more effective than using either drug alone at reducing skin thickness and improving…
Articles by Patricia Inácio, PhD
People with systemic sclerosis (SSc) face significantly worse sleep quality than those with rheumatoid arthritis (RA) and healthy people,…
CAL101, a therapy candidate for fibrosis (scarring) in scleroderma and related disorders, was found to be safe and well…
Intravenous immunoglobulin (IVIG) eases skin, muscle and digestive symptoms in people with scleroderma (SSc), particularly when used as…
Scleroderma patients who have cancer may be treated with radiotherapy without a notable risk of skin and pulmonary worsening,…
Cells present along the walls of small blood vessels in the lungs, called pericytes, have distinct gene activity in people…
The European Medicines Agency (EMA) has granted orphan drug status to FT011, an oral therapy candidate that Certa…
The first healthy volunteers have been dosed in a Phase 1 clinical study that’s evaluating MDI-2517, a…
Anti-SSA self-reactive antibodies, a hallmark of Sjögren’s syndrome, are associated with a higher risk of organ involvement in people…
Anemia is found in almost 20% of people with systemic sclerosis (SSc) and is associated with an almost two…